{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:14:04Z","timestamp":1782890044908,"version":"3.54.5"},"reference-count":30,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,5,1]]},"abstract":"<jats:p>Objective. In 1994, the American Academy of Pediatrics (AAP) published a practice guideline with age-specific thresholds for phototherapy for healthy term newborns with hyperbilirubinemia. The purpose of this study was to examine adherence to the guideline in a large managed care organization.<\/jats:p><jats:p>Methods. We conducted a retrospective cross-sectional analysis of linked computerized databases from 11 Northern California Kaiser Permanente Medical Care Program hospitals. Newborn infants included were at least 37 weeks of gestation, had birth weights of at least 2500 g, and were born between January 1, 1995, and December 31, 1996. The primary outcome variable for the study was receipt of phototherapy according to the guideline. Total serum bilirubin (TSB) and infant age in hours at the time of bilirubin measurement were used to classify infants into 3 groups according to the AAP guideline: recommend phototherapy (R), consider phototherapy (C), and did not recommend phototherapy (N). Group R included infants with TSB levels of at least 15 mg\/dL before 48 hours of age, at least 18 mg\/dL before 72 hours, or at least 20 mg\/dL after 72 hours. Group C included infants not in group R, with TSB levels of at least 12 mg\/dL before 48 hours, 15 mg\/dL before 72 hours, or at least 17 mg\/dL after 72 hours. Group N included infants who were in neither group R nor group C and also did not have significant jaundice before 24 hours of age. Phototherapy codes from electronic databases were validated by chart review for a subset of 550 infants.<\/jats:p><jats:p>Results. Compared with chart review, phototherapy codes in the database were 94.4% sensitive (95% confidence interval [CI]: 89.1%\u201397.5%) and 100% specific (95% CI: 99.25%\u2013100%). Among the 47 801 infants eligible, 2.3% received phototherapy. Phototherapy was administered to 54% of 1194 infants in group R (range across hospitals: 27%\u201377%), 16% of 2245 infants in group C (range: 5%\u201337%), and 0.2% of 44 362 infants in group N (range: 0.1%\u20130.6%). The predictors of phototherapy for group R, the group for whom phototherapy was recommended, determined by logistic regression were increasing TSB levels (odds ratio [OR]: 1.6\/mg\/dL; 95% CI: 1.4\u20131.7), reaching the AAP threshold at 24 to 47.9 hours of age compared with 48 hours or more (OR: 7.1; 95% CI: 4.3\u201311.9), gestational age of 37 weeks compared with 38 weeks or more (OR: 1.6; 95% CI: 1.1\u20132.3), age when phototherapy was first recommended (OR: 0.7\/d; 95% CI: 0.6\u20130.8), and facility of birth (OR: 0.2\u20132.7). The facility of birth was a strong predictor of phototherapy use in all groups (R, C, and N).<\/jats:p><jats:p>Conclusions. Clinicians provided phototherapy to only 54% of term infants with hyperbilirubinemia for whom it was recommended by the AAP. There is marked interhospital variation in phototherapy use in this large managed care system. Improved adherence to the guideline would require only a slight increase in the total rate of phototherapy use if unnecessary use for infants with lower levels of TSB were simultaneously decreased.<\/jats:p>","DOI":"10.1542\/peds.111.5.e555","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:43:47Z","timestamp":1092444227000},"page":"e555-e561","source":"Crossref","is-referenced-by-count":57,"title":["Phototherapy Use in Jaundiced Newborns in a Large Managed Care Organization: Do Clinicians Adhere to the Guideline?"],"prefix":"10.1542","volume":"111","author":[{"given":"Lee R.","family":"Atkinson","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Stanford University Medical Center, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel J.","family":"Escobar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kaiser Permanente Medical Center, Walnut Creek, California, and Kaiser Permanente Division of Research, Perinatal Research Unit, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John I.","family":"Takayama","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Newman","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"},{"name":"Epidemiology and Biostatistics, University of California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2003,5,1]]},"reference":[{"key":"2021121003343187200_R1","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics.1994;94:558\u2013565","DOI":"10.1542\/peds.94.4.558"},{"key":"2021121003343187200_R2","doi-asserted-by":"crossref","unstructured":"Lewak N. Management of idiopathic hyperbilirubinemia in term infants: community practices. Pediatrics.1974;53:471\u2013475","DOI":"10.1542\/peds.53.4.471"},{"key":"2021121003343187200_R3","doi-asserted-by":"crossref","unstructured":"Gartner L. Practice patterns in neonatal hyperbilirubinemia. Pediatrics.1998;101:25\u201331","DOI":"10.1542\/peds.101.1.25"},{"key":"2021121003343187200_R4","doi-asserted-by":"crossref","unstructured":"Guaran RL, Drew JH, Watkins AM. Jaundice: clinical practice in 88,000 liveborn infants. Aust N Z J Obstet Gynaecol.1992;32:186\u2013192","DOI":"10.1111\/j.1479-828X.1992.tb01942.x"},{"key":"2021121003343187200_R5","doi-asserted-by":"crossref","unstructured":"Hansen T. Therapeutic approaches to neonatal jaundice: an international survey. Clin Pediatr.1996;35:309\u2013316","DOI":"10.1177\/000992289603500604"},{"key":"2021121003343187200_R6","doi-asserted-by":"crossref","unstructured":"Seidman DS, Paz I, Armon Y, Ergaz Z, Stevenson DK, Gale R. Effect of publication of the \u201cPractice Parameter for the management of hyperbilirubinemia\u201d on treatment of neonatal jaundice. Acta Paediatr.2001;90:292\u2013295","DOI":"10.1080\/08035250120100"},{"key":"2021121003343187200_R7","doi-asserted-by":"crossref","unstructured":"Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med.2000;154:1140\u20131147","DOI":"10.1001\/archpedi.154.11.1140"},{"key":"2021121003343187200_R8","doi-asserted-by":"crossref","unstructured":"Escobar GJ, Gardner MN, Chellino M, Fireman B, Verdi J, Yanover M. Identification of neonatal deaths in a large managed care organization. Paediatr Perinat Epidemiol.1997;11:93\u2013104","DOI":"10.1111\/j.1365-3016.1997.tb00800.x"},{"key":"2021121003343187200_R9","doi-asserted-by":"crossref","unstructured":"Newman TB, Escobar GJ, Gonzales V, Armstrong MA, Gardner M, Folck B. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics.1999;104:1198\u20131203","DOI":"10.1542\/peds.104.S6.1198"},{"key":"2021121003343187200_R10","doi-asserted-by":"crossref","unstructured":"Selby JV. Linking automated databases for research in managed care settings. Ann Intern Med.1997;127:719\u2013724","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00056"},{"key":"2021121003343187200_R11","doi-asserted-by":"crossref","unstructured":"Cavalier S, Escobar GJ, Fernbach SA, Quesenberry CP Jr, Chellino M. Postdischarge utilization of medical services by high-risk infants: experience in a large managed care organization. Pediatrics.1996;97:693\u2013699","DOI":"10.1542\/peds.97.5.693"},{"key":"2021121003343187200_R12","doi-asserted-by":"crossref","unstructured":"Escobar GJ, Fischer A, Kremers R, Usatin MS, Macedo AM, Gardner MN. Rapid retrieval of neonatal outcomes data: the Kaiser Permanente Neonatal Minimum Data Set. Qual Manag Health Care.1997;5:19\u201333","DOI":"10.1097\/00019514-199705040-00003"},{"key":"2021121003343187200_R13","doi-asserted-by":"crossref","unstructured":"Escobar GJ, Joffe S, Gardner MN, Armstrong MA, Folck BF, Carpenter DM. Rehospitalization in the first two weeks after discharge from the neonatal intensive care unit. Pediatrics.1999;104(1). Available at: www.pediatrics.org\/cgi\/content\/full\/104\/1\/e2","DOI":"10.1542\/peds.104.1.e2"},{"key":"2021121003343187200_R14","doi-asserted-by":"crossref","unstructured":"Escobar GJ. The neonatal \u201csepsis work-up\u201d: personal reflections on the development of an evidence-based approach toward newborn infections in a managed care organization. Pediatrics.1999;103:360\u2013373","DOI":"10.1542\/peds.103.SE1.360"},{"key":"2021121003343187200_R15","doi-asserted-by":"crossref","unstructured":"Cabana MD, Rand CS, Powe NR, et al. Why don\u2019t physicians follow clinical practice guidelines? A framework for improvement. JAMA.1999;282:1458\u20131465","DOI":"10.1001\/jama.282.15.1458"},{"key":"2021121003343187200_R16","doi-asserted-by":"crossref","unstructured":"Christakis DA, Rivara FP. Pediatricians\u2019 awareness of and attitudes about four clinical practice guidelines. Pediatrics.1998;101:825\u2013830","DOI":"10.1542\/peds.101.5.825"},{"key":"2021121003343187200_R17","unstructured":"Brown AK, Johnson L. Loss of concern about jaundice and the reemergence of kernicterus in full term infants in the era of managed care. In: Fanaroff A, Klaus M, eds. Yearbook of Neonatal and Perinatal Medicine. St Louis, MO: Mosby Yearbook; 1996:xvii\u2013xxviii"},{"key":"2021121003343187200_R18","doi-asserted-by":"crossref","unstructured":"Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr.2000;89:1213\u20131217","DOI":"10.1111\/j.1651-2227.2000.tb00738.x"},{"key":"2021121003343187200_R19","doi-asserted-by":"crossref","unstructured":"Hansen TW. Kernicterus in a full-term infant: the need for increased vigilance. Pediatrics.1995;95:798\u2013799","DOI":"10.1542\/peds.95.5.798"},{"key":"2021121003343187200_R20","doi-asserted-by":"crossref","unstructured":"Stanley TV. A case of kernicterus in New Zealand: a predictable tragedy?J Paediatr Child Health.1997;33:451\u2013453","DOI":"10.1111\/j.1440-1754.1997.tb01641.x"},{"key":"2021121003343187200_R21","doi-asserted-by":"crossref","unstructured":"Boggs T, Hardy J, Frazier T. Correlation of neonatal serum total bilirubin concentration and developmental status at age eight months. Preliminary report from the collaborative project. J Pediatr.1967;71:553\u2013560","DOI":"10.1016\/S0022-3476(67)80107-0"},{"key":"2021121003343187200_R22","doi-asserted-by":"crossref","unstructured":"Scheidt P, Mellits E, Hardy J, et al. Toxicity to bilirubin in neonates. Infant development during first year in relation to maximum neonatal serum bilirubin concentration. J Pediatr.1977;91:292\u2013297","DOI":"10.1016\/S0022-3476(77)80835-4"},{"key":"2021121003343187200_R23","doi-asserted-by":"crossref","unstructured":"Newman TB, Klebanoff MA. Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. Pediatrics.1993;92:651\u2013657","DOI":"10.1542\/peds.92.5.651"},{"key":"2021121003343187200_R24","doi-asserted-by":"crossref","unstructured":"Seidman DS, Paz I, Stevenson DK, Laor A, Danon YL, Gale R. Neonatal hyperbilirubinemia and physical and cognitive performance at 17 years of age. Pediatrics.1991;88:828\u2013833","DOI":"10.1542\/peds.88.4.828"},{"key":"2021121003343187200_R25","doi-asserted-by":"crossref","unstructured":"Soorani-Lunsing I, Woltil HA, Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain?Pediatr Res.2001;50:701\u2013705","DOI":"10.1203\/00006450-200112000-00012"},{"key":"2021121003343187200_R26","unstructured":"Seidman DS, Paz I, Stevenson DK, Laor A, Danon YL, Gale R. Effect of phototherapy for neonatal jaundice on cognitive performance. J Perinatol.1994;14:23\u201328"},{"key":"2021121003343187200_R27","unstructured":"Scheidt PC, Bryla DA, Nelson KB, Hirtz DG, Hoffman HJ. Phototherapy for neonatal hyperbilirubinemia: six-year follow-up of the National Institute of Child Health and Human Development clinical trial. Pediatrics.1990;85:455\u2013463"},{"key":"2021121003343187200_R28","doi-asserted-by":"crossref","unstructured":"Maisels MJ, Newman TB. Bilirubin and neurological dysfunction\u2014do we need to change what we are doing?Pediatr Res.2001;50:677\u2013678","DOI":"10.1203\/00006450-200112000-00006"},{"key":"2021121003343187200_R29","doi-asserted-by":"crossref","unstructured":"Watchko J, Oski F. Bilirubin 20 mg\/dL = vigintiphobia. Pediatrics.1983;71:660\u2013663","DOI":"10.1542\/peds.71.4.660"},{"key":"2021121003343187200_R30","doi-asserted-by":"crossref","unstructured":"Newman TB, Maisels MJ. Less aggressive treatment of neonatal jaundice and reports of kernicterus: lessons about practice guidelines. Pediatrics.2000;105:242\u2013245","DOI":"10.1542\/peds.105.S2.242"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/111\/5\/e555\/1002160\/pe050300e555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/111\/5\/e555\/1002160\/pe050300e555.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:42:51Z","timestamp":1682746971000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/111\/5\/e555\/63273\/Phototherapy-Use-in-Jaundiced-Newborns-in-a-Large"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,1]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2003,5,1]]},"published-print":{"date-parts":[[2003,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.111.5.e555","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,1]]}}}